MrC's Smallcap Sweeps for Feb 2023

[MrContrarian]

Smallcap Sweep. 01-Feb-23
Arresting language

Argo Blockchain (ARB) CFO scarpers. He is thanked. "I am very proud of what we have achieved over my time with Argo." His sense of humour will be missed. [SP=15.6 Cap=95m]
ECSC (ECSC) £690k of contracts. [SP=21 Cap=2m]
Made Tech, (MTEC) guides H1-Nov rev up 76%. Adj EBITDA £0.5m, in line. Guides FY in line. [SP=26.88 Cap=40m]
Harland & Wolff (HARL) big contract announed in Jan now formally signed. [SP=20 Cap=35m]
BSF Enterprise (BSFA) has successfully produced the UK's first steak fillet of structured cultivated meat. [SP=18.5 Cap=16m]
Aurrigo (AURR) £0.7m grant to provide three self-driving zero-emission Auto-Shuttles. [SP=81.25 Cap=34m]
Foresight (FSG) appointment as sub-adviser to the Cromwell Foresight Global Sustainable Infrastructure Fund. a newly formed partnership between Foresight and Cromwell. [SP=461 Cap=536m]
Gaming Realms (GMR) guides FY-Dec rev up 27% and adj EBITDA up 36%. In line? CFO becomes CEO. [SP=28.4 Cap=83m]
Crimson Tide (TINE) £0.25m+ inaugural subscription contract in USA. "This contract win is a landmark in its own right." As opposed to just a landmark? [SP=NA Cap=NA]

In line: TND, WYN
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 02-Feb-23
Magic Mirror on the wall, whch is the cheapest one of all?

Superdry (SDRY) CEO Dunkerton re rumour he considering taking it private, "No plans to do this at the moment.” RNS is a daft "Statement Regarding Superdry Plc". [SP=121.32 Cap=100m]
Streaks Gaming (STK) ad partnership with FanDuel, the no 1 sportsbook in the US. STK is "a GPT-driven conversational gaming platform". How does that work? User: "What's the fastest way to lose money?" GPT: "Try online gaming." [SP=2.89 Cap=11m]
Dianomi (DNM) guides FY-Dec in line but "recent report from e-Marketer suggested that publishers' advertising businesses are having a difficult start to the year, though indications of Q2 budgets are looking more positive...market forecasts...reduced to show modest levels of growth for this year". [SP=65.5 Cap=20m]
Peel Hunt (PEEL) REX to relaunch as RetailBook with ollaboration with Hargreaves Lansdown, Jefferies, Numis and Rothschild. [SP=107 Cap=131m]
Immotion (IMMO) new 3-year framework with Merlin covering the 26 sites at which Immotion has already installed or agreed to install a VR attraction. [SP=2.2 Cap=9m]
Esken (ESKN) warns FY-Feb EBITDA of £20m £2m below guidance due to biomass plant customers having unplanned outages. [SP=5.9 Cap=59m]
Lords Group Trading (LORD) sells Lords at Home biz for £805k. It sells high quality homewares through five branches across West London. [SP=84 Cap=137m]
Dillistone (DGS) guides FY-Dec broadly in line with market expectations before acquisition related items and other one-off adjustments. [SP=NA Cap=NA]
Smarttech247 (S247) the recent IPO wins contracts worth over $850k. [SP=29.15 Cap=NA]
PCI-PAL (PCIP) guides H1-Dec rev up 33%. Adj EBITDA -£0.6m, better than management expectations. Guides FY in line. [SP=56.01 Cap=37m]
Xpediator (XPD) guides FY-Dec rev c.£400m. Adj pretax expected to be significantly ahead of previous management guidance of £9m. [SP=38.54 Cap=55m]

In line: ING, SCS, JHD, SFE
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 03-Feb-23
I will look for you, I will find you, and I will grill you.

MGC Pharmaceuticals (MXC) gets $600k funding the $10m Convertible Securities Financing Facility with Mercer Street Global Opportunity Fund, CFO scarpers. She is not thanked. [SP=0.58 Cap=35m]
Triple Point Social Housing REIT (SOHO) arrears reach 8% (0.2%) due to two lessees. "The Board recognises the ongoing resilience of the Company's portfolio, notwithstanding the sector-wide pressures social housing providers are experiencing." [SP=50.81 Cap=205m]
Itaconix (ITX) £10.3m placing at 5.1p, a 5% discount, for general working capital purposes to support continued revenue growth. [SP=5.5 Cap=25m]
CMO (CMO) guides FY-Dec rev up 9%, LFL 2%. Adj EBITDA c.£2.1m (£3.7m). In line? "Despite the macro-economic and industry headwinds seen in 2022, CMO delivered significant sales growth." But it's less than inflation. [SP=27.5 Cap=20m]
Avation (AVAP) guides H1-Dec rev c.$46m (no comparative given). In fact it's down 23%. Total contracted future lease revenue receivable $509m ($568m). In line? Not helpful. [SP=131 Cap=91m]

In line: TUNE
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 06-Feb-23
Fanning the blames

SEEEN (SEEN) guides FY-Dec rev c.$3.3m ($8.5m) and adj EBITDA loss $0.8-0.9m ($1.5m). Blames a raft of things including weak weak Q4 and exchange rates. Contract worth c.$1m in annual rev. [SP=6 Cap=5m]
EPE Special Opportunities (ESO) NAV end Jan 334p/sh down 27%. [SP=170 Cap=70m]
Seeing Machines (SEE) agreement with Mobileye Vision to incorporate the Mobileye suite of Aftermarket products into Guardian. [SP=6.9 Cap=288m]
CyanConnode (CYAN) Indian framework agreement to provide 3m smart meters together with Omnimesh RF modules, Advanced Metering Infrastructure, Standards-Based Hardware, Omnimesh Head-End Software. Underpins directors' confidence in the market expectations to Dec 24. [SP=22.5 Cap=61m]
Pressure Technologies (PRES) £18.2m 3 yr contract, underpinning current market expectations. [SP=38.2 Cap=15m]
EQTEC (EQT) guides FY22 rev in line. Profit? [SP=0.28 Cap=27m]
Immupharma (IMM) agrees a Phase 2/3 adaptive trial for Lupuzor with its partner Avion Pharmaceuticals. [SP=2.66 Cap=9m]
Iofina (IOF) guides FY22 rev inn line and EBITDA $10.5m+, materially ahead of market forecast. [SP=25 Cap=49m]
B90 (B90) issues another £500k converts (death spiral?) to keep the lights on. Also £112,500 Loan Notes to a key marketing partner in lieu of cash. Trading in line. [SP=3 Cap=9m]
Engage XR (EXR) £8.8m placing at 4p, a 20% discount, "in order to capitalise on the growth exhibited in FY22". Mainly for working cap. Trading: over €4m in contract value for ENGAGE subscriptions closed in FY-Dec. [SP=4.75 Cap=14m]
Bonhill (BONH) formal sale process ends - no offer for who co. A UK media company's due diligence on the assets and trade of its UK and Asia businesses is progressing well; $6.5m non-binging offer for InvestmentNews. Warns FT-Dec rev £13.6m and EBITDA -£1.5m as some lients continued to delay the release of planned marketing spend. [SP=7.4 Cap=8m]
EKF Diagnostics (EKF) guides FY-Dec rev in line but adj EBITDA slightly below market expectations. Supply and delivery of the largest 14,500 litre fermenter in Indiana has been delayed. Wil hit Life Sciences rev. [SP=40 Cap=182m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 07-Feb-23
Easy jogs or hard slogs

Water Intelligence (WATR) guides FY-Dec rev up 31%, adj pretax up 12%. In line? Buys out Nashville franchise. [SP=580 Cap=114m]
SmartSpace Software (SMRT) guides FY-Jan rev up 36% in line. LBITDA better than market expectations. "We have had more churn than we would have liked from our Space Connect base. As the Covid-related regulatory pressure eased last year, these churns came up at annual renewal. However, more positively, new customers are purchasing our solutions to implement their space optimisation policies." [SP=42 Cap=12m]
Live Company (LVCG) 50/50 JV in Japan. [SP=1.9 Cap=5m]
e-therapeutics (ETX) four new patent applications on novel target innovation and new short interfering RNA chemistries. [SP=17.2 Cap=100m]
Numis (NUM) AGM stmt: last 4 months rev flat as difficult market conditions persist. [SP=220.16 Cap=242m]
Zinc Media (ZIN) guides FY22 rev and adj EBITDA ahead of market expectations. FY23 bookings £15m (£9m). [SP=82.25 Cap=18m]
Sanderson Design (SDG) guides FY-Jan rev flat. Underlying profit in line with mgmt exp. [SP=130 Cap=93m]
IXICO (IXI) guides FY-Sept 23 rev in line. Now expects to achieve double digit rev growth in FY24. [SP=25 Cap=12m]
Tanfield (TAN) timetable for the US Proceedings in Snorkel dispute delayed to early 2024. [SP=2.56 Cap=4m]
Northcoders (CODE) to buy Tech Returners, a leading UK technology re-training business, for £1.576m in cash and shares. [SP=300.2 Cap=23m]
REACT (REAT) FY-Sept. Positive outlook. [SP=1.19 Cap=13m]

In line: FEN, EISB, EBQ, ANX, ALU
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 08-Feb-23
Frogmarching failures to the sin bin

Cellular Goods (CBX) car crash co terminates proposed acquisition of Cannaray Brands and Love CBD Health from Cannaray as a result of changes in the deal itself.Co "proactively reviewing its product range, proposition, financials, strategy and opportunities". [SP=0.61 Cap=3m]
Sosandar (SOS) £4.5m placing and retail offer at 22p, a 17% discount (not mentioned), to accelerate the execution of its omni-channel strategy and customer acquisition. [SP=26.5 Cap=59m]
Speedy Hire (SDY) finds c.£20m of hire assets gone missing, a huge 41% of non-itemised items like scaffolding. Launches external investigation. Trading in line. [SP=41.57 Cap=195m]
Pennant (PEN) guides FY-Dec rev down 14%, EBITA c. £0.5m (-£0.8m) thanks to margin improvement. 3 year order book £25m (£22m). In line? [SP=28.99 Cap=11m]
Renalytix (RENX) $20.3m placing at $2.17 per ADR = 90p/ord, a 27% discount (not mentioned), mainly for clinical product development and marketing. [SP=124.75 Cap=116m]
Renold (RNO) guides FY23 rev and U/L op profit above market forecasts. Cites "continued sales growth, a strong orderbook, benefits of the cost reduction and efficiency programmes, and the successful recovery of cost inflation on raw material and energy". [SP=24.57 Cap=55m]
Cenkos Securities (CNKS) guides FY-Dec rev c.£20m and breakeven U/L profit. In line? Outlook - more encouraging start to 2023. [SP=51 Cap=29m]
M & C Saatchi (SAA) guides FY22 rev in line and adj pretax £31.8m, slightly ahead. Current trading in line. Capital markets day with new strategy with cost savings and new capabilities, with a focus on data, technology and digital transformation. Targets headline earnings growth of 22% CAGR. [SP=169.92 Cap=208m]

In line: CSH
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 09-Feb-23
Financial fillies and also-rans

Argo Blockchain (ARB) CEO scarpers. He is thanked. NED also leaves. [SP=18.2 Cap=89m]
Graft Polymer (GPL) nearly completed installation of the new production lines to double production. Also an order from a cosmetic company, a first for Graft Polymer. [SP=12.1 Cap=13m]
Zytronic (ZYT) AGM stmt - H2 weighting will be greater than previous FY due to continuing supply chain issues and the increasingly robust opportunities pipeline. Warns that pay rises for staff and other inflation may exceed budget. [SP=155 Cap=16m]
Malvern (MLVN) guides FY-Dec rev up 170% and pretax loss c.£1.1m (£1.6m adjusted for Singapore disposal). Jan uptake for University Pathways significantly ahead of mgmt expectations. English Learning Training - confident. [SP=14.5 Cap=4m]
Avon Protection (AVON) further $6.7m order from US Defense Logistics Agency under the second-generation Advanced Combat Helmet contract. [SP=980 Cap=295m]
Journeo (JNEO) guides FY-Dec rev up 35%. Profit in line with market expectations. Order intake up 50%. [SP=127.8 Cap=21m]
Fusion Antibodies (FAB) new service, Mammalian Display, for high volume mammalian cell surface expression and screening of antibodies. [SP=40 Cap=10m]
Shield Therapeutics (STX) guides FY-Dec rev £8.5m (£1.5m) inc £4.4m in licence payments. [SP=6.14 Cap=36m]
genedrive (GDR) Antibiotic Induced Hearing Loss test receives preliminary recommendation by NICE. Final guidance will follow a public consultation [SP=25 Cap=23m]

In line: OMG, SUS
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 10-Feb-23
Friday fluff

itim (ITIM) guides FY-Dec rev c.£14m, in line but EBITDA onlu c.£0.2m (£2.2m), below market expectations. Blames slow enterprise contract conversion. [SP=47.2 Cap=15m]
Saga (SAGA) confirms exclusive discussions with Open Insurance Technologies on sale of underwriting business. [SP=170.9 Cap=240m]
Ince (INCE) the late FY-Mar audit needs two more weeks work. [SP=4.95 Cap=19m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 14-Feb-23
All ship-shape at Braemar

Amigo (AMG) censured by FCA for failing to conduct adequate affordability checks on borrowers and guarantors. Fine would have been £73m, however Amigo demonstrated that this would cause it serious financial hardship and threaten compensation scheme. [SP=NA Cap=NA]
Braemar (BMS) has continued to trade well. In line? Plans capital reduction to increase distributable reserves. [SP=316 Cap=104m]
Palace Capital (PCA) sells industrial property in Plymouth for £3.2m, marginally ahead of book. Sees "encouraging signs of stabilisation in asset pricing in the commercial real estate market". [SP=200 Cap=88m]
Kanabo (KNB) biz update. Plans to launch additional formulations with low-THC compounds over the coming month. Has doubled number of consultations pcm since the acquisition of the GP service. [SP=3.47 Cap=15m]
Altitude (ALT) guides FY-Mar materially ahead of market expectations. Expects rev and EBITDA growth throughout remainder of calendar 2023 and 2024. [SP=33.1 Cap=23m]

In line: ADF, UPGS
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 15-Feb-23
Business qualities and frivolities

Mercantile Ports & Logistics (MPL) dredges up another bucket of hope. Handles its first container freight albeit with small initial volumes. Also MoU with another port on "collaboration on the movement of shipping containers and vehicles by coastal waterways". Latter will have no material impact this FY. [SP=6 Cap=2m]
Gattaca (GATC) guides H1-Jan net fee income up 5%. In line? Outlook - "softening in some external sectors, and perm is likely to be impacted by a level of restraint around hiring, shifting candidate sentiment and, as such, slightly longer hiring cycles." [SP=88.2 Cap=28m]
Sondrel (SND) guides FY-Dec rev up 116%. In line? Design wins in line with expectations. Warns of project delays this FY. [SP=60 Cap=53m]
LPA Group (LPA) wins £5.3m order for the supply of electro-mechanical products to the UK rail industry. Sales expected to commence towards the end of current FY. Guides FY23 in line with mgmt expectations. [SP=75.21 Cap=10m]

In line: PIER
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 16-Feb-23
You have won first prize in a mug punter contest. Collect 100 worthless shares.

Chill Brands (CHLL) co's website selling its first 3rd party product, Mad Tasty drinks. Mad Tasty was founded by the lead singer of OneRepublic, Ryan Tedder. Like we give a [expletive deleted]. "We are thrilled to be joining the Chill.com marketplace" trills the president of swallowing BS. I guess passengers were thrilled to step aboard the Titanic and the Hindenburg, [SP=NA Cap=NA]
Home REIT (HOME) sinking ship hoists For Sale flag. Only 23% of rent has been collected in Q-Nov. Serious challenges in rent collection for Dec and Jan. C.25% (by beds) of properties require at least some level of refurbishment. Considering all strategic options. [SP=38.7 Cap=301m]
booHoo (BOO) new Growth Share Plan since last one isn't paying out. "The introduction of the Growth Plan will drive long-term sustainable growth" just like the 2019 one, er, didn't. 6% max dilution. Hardles based on SP alone, from 95p. [SP=46.9 Cap=592m]
Libertine (LIB) signs Term Sheet with Azelio AB to jointly integrate and licence Libertine's HEXAGEN platform for energy storage applications. [SP=20.59 Cap=27m]
Jaywing (JWNG) warns FY-Mar rev only £22-£22.5m, with adjusted EBITDA ahead of last year due to cost reductions, but below market expectations. "Jaywing has seen a softening of demand over the past two months with certain clients seeking to defer their marketing spend." [SP=6.75 Cap=6m]
OnTheMarket (OTMP) secondary placing of 3.1m shares at 76p, 2% below mid. [SP=75.05 Cap=57m]
Checkit (CKT) guides FY-Jan rev up 22%. ARR up 28% vs 20% expectations. So total rev in line? "Non-recurring revenue declined compared to FY22 as planned." [SP=NA Cap=NA]
t42 IoT Tracking Solutions (TRAC) guides FY-Dec rev c.$4m. In line? Sales from Openbox, the new distributor in the USA, disappoint. Co "focusing on the need to accelerate upfront cash payments to suppliers to shorten the supply chain period and ensure delivery preference". Or they could just do it. [SP=NA Cap=NA]
Creo Medical (CREO) £25m placing and £5.2m OO at 20p, a 28% discount, to keep the lights on. [SP=28 Cap=51m]

In line: IHC
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 17-Feb-23
Bricks and slaughter

Purplebricks (PURP) puts up For Sale board on itself. Cuts FY-Apr guidance - rev £60-65m and adj EBITDA loss £15-20m. Blames disruption from move to focus on profitable areas and those with largest opportunity for market share growth. Plans another £4m cost savings. [SP=10.19 Cap=31m]
booHoo (BOO) my goodness! Having a vote on the 'Growth Plan'. Sounds better than 'Option for Management To Turn Things Round Plan'. I mean, who's against growth? [SP=48.63 Cap=617m]
Harland & Wolff (HARL) negotiates £16m payment from Saipem the terminated contract. "The project has been a helpful learning curve for the business in this environment." [SP=15 Cap=26m]
CML Microsystems (CML) conditional planning approval granted at its current 29-acre site in Maldon. Final approval is subject to the completion of the necessary Section 106 Unilateral Undertakings. [SP=553.5 Cap=88m]
Oncimmune (ONC) partners with Siemens to improve malignancy risk assessment of indeterminate pulmonary nodules. [SP=53.55 Cap=40m]
EnSilica (ENSI) wins €5m contract to develop a new chip to address the next generation of mass market satellite broadband user terminals. [SP=95 Cap=71m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 20-Feb-23
May contain cuts

Trifast (TRI) cuts and jolts at the nuts and bolts co. Warns FY-Mar significantly below market expectations with rev £243m and adjusted pretax c.£9m. Blames destocking and higher debt,and so higher net interest charges. Review has found cost cuts of c.£5m PA. CEO scarpers. He is thanked. [SP=92 Cap=125m]
Tekcapital (TEK) £2.25m placing at 16p, a 21% discount (not worth a mention), for capital for its investees, and working cap. [SP=20 Cap=30m]
Harland & Wolff (HARL) wins £10m of contracts over 12-18 months. [SP=14.63 Cap=25m]
Litigation Capital (LIT) Carillion claim funding pays out 2.8x invested cap. Gross profit AUD6.3m. [SP=66.5 Cap=79m]
Keystone Law (KEYS) guides FY-Jan rev and adj pretax marginally ahead of current market expectations. [SP=480 Cap=151m]
Verditek (VDTK) distributor Bradclad's termination will take effect from 3 March as expected. [SP=0.68 Cap=3m]
GSTechnologies (GST) stablecoin application for admission to the FCA's Regulatory Sandbox. Plans to issue stablecoins and provide trusted stablecoin-based payments services to the UK market and beyond. [SP=0.31 Cap=5m]
Roquefort Therapeutics (ROQ) licenses Midkine antibodies to Randox Laboratories [SP=6.55 Cap=9m]
Proteome Sciences (PRM) guides FY-Dec rev up 53% and EBITDA c£2m (£0.6m). In line? Outlook - "significant order book being carried forward, our business is strongly positioned". [SP=3.9 Cap=11m]
Eleco (ELCO) sells Eleco Software GmbH for €600k. [SP=81 Cap=69m]
Ten Lifestyle (TENG) wins a new digitally enabled concierge programme in the Americas. Medium size. Also an existing client agrees to pay Ten materially more per member to further drive their customer loyalty objectives. [SP=89.8 Cap=75m]

In line: DARK, WIL
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 21-Feb-23
Wake up and sell the coffin

Everest Global (EVST) will miss deadline for FY22 Results (1 March). Due to being unable to get an auditor with Public Interest Entity Auditor Registration Regulations approval. Co expects to finalise the appointment of an alternative audit firm shortly. What a shambles. [SP=3.5 Cap=2m]
Versarien (VRS) FY-Sept. FY was extended to 18 months. Material uncertainty going concern stmt. Assumes it wins some grants, otherwise will need fundraise, another death-spiral etc. Graphene rev £2.1m (£0.7m). Loss £8.4m (£8.1m). Cash at hand £1.4m end Sept. Co "streamlining the business" ie loads of jobs gone. Ricketts laments "current macro-economic conditions combined with the disruptive nature of our products has delayed the commercialisation we were anticipating". [SP=6.82 Cap=15m]
Aurrigo International (AURR) partnership agreement with Changi Airport Group for the continued joint development and testing of co's autonomous vehicles plus airport simulation software platform Auto-Sim. [SP=119 Cap=50m]
Spectral MD (SMD) EU clinical study for its Diabetic Foot Ulcer application for the Company's DeepView technology. "There is currently no diagnostic tool available for early wound healing diagnosis." [SP=32 Cap=41m]
Zoo Digital (ZOO) major Hollywood studioadopts ZOO's Globalisation Management Platform to support their content localisation. This client is also using ZOOstudio to manage localisation of content across its vendors. [SP=164 Cap=146m]
Revolution Beauty (REVB) expects to publish delayed FY22 accounts on or around 30 Mar. Remains suspended. [SP=19 Cap=26m]
Scancell (SCLP) encouraging early efficacy data fr.om monotherapy part of ModiFY Phase 1/2 clinical trial [SP=18.5 Cap=151m]

In line: CARR
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 22-Feb-23
Applied Graphene Materials has slipped away

Powerhouse Energy (PHE) Framework Services agreement by which Petrofac will provide engineering design and supply chain development services on PHE's pipeline of projects. [SP=1.1 Cap=44m]
Applied Graphene Materials (AGM) proposes to sell biz for $1.3m and de-list. Strategic review showed business can no longer continue as an independent entity. Nowt left for shareholders. [SP=5.5 Cap=3m]
Science in Sport (SIS) guides FY-Dec broadly in-line with expectations. Margins in line. Outlook in line. [SP=12.5 Cap=22m]
Sanderson Design (SDG) 5 year licensing agreement for its Clarke & Clarke brand with Next. Licensed products will be sold from 2024. £2.6m will be booked this FY. [SP=122 Cap=87m]
C4X Discovery (C4XD) Garvan Institute of Medical Research reports successful Parkinson's patient stratification approach using C4XD's new precision medicine platform PatientSeek. [SP=17 Cap=43m]
Kinovo (KINO) £12m five year contract from Hyde for electrical testing and associated works. Also awarded first position on the Hyde Framework Agreement. [SP=37 Cap=23m]

In line: ANG, SEE, TRT, AVG, GHH, SNX
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 23-Feb-23
Till Debt Us Do Part

SIMEC Atlantis Energy (SAE) asks bondholders for a deferral of the repayment date of end Mar. Promises them some money is coming in. [SP=1.55 Cap=11m]
Amigo (AMGO) still passing the hat round potential investors. Pilot lending scheme: grown significantly through January and February after a poor start. Hikes compensation provision again by £15.9m. [SP=2.5 Cap=12m]
Litigation Capital Management (LIT) $2m case investment: "partial award on liability and quantum was granted in favour of the funded party. This means that the funded party has succeeded in the claim". [SP=69.31 Cap=81m]
Arbuthnot Banking Group (ARBB) guides FY-Dec pretax beat. F/C is £17.3m. [SP=890 Cap=133m]
TT Electronics (TTG) guides FY-Dec rev up 20%, ahead of expectations. Adj pretax at or around the top end of the range of expectations of £36.5m to £39.4m. [SP=181 Cap=319m]
DG Innovate (DGI) Collaboration Framework Agreement with two tier 1 commercial vehicle and off-highway axle suppliers. It "reflects the desire of all three parties to collaborate, in order to establish a significant position in the growing heavy vehicle electric drivetrain market". [SP=0.12 Cap=11m]
System1 (SYS1) Q3 rev down 4%. Gross margin up on H1. [SP=167 Cap=21m]

In line: TRCS
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 24-Feb-23
Tragic Roundabout

Cineworld (CINE) has non-binding proposals to buy some or all of its business. None of these is an all-cash bid for the entire business. Shareholders unlikely to get even a bag of popcorn to munch through the end of this disaster [SP=4 Cap=55m]
Kin and Carta (KCT) warns FY-July adjusted operating profit below market expectations. Blames more cautionary client spending and elongated sales cycles. H1 rev up 15%. LFL-constant currency rev down 6%. [SP=186 Cap=331m]
Circle Property (CRC) sells its largest remaining asset fr c.£12.3m. Net proceeds will be returned to holders, as announced. Will seek to de-list. [SP=207 Cap=60m]
Avation (AVAP) guides FY-June significantly ahead of market expectations due to "a combination of factors such as lower than anticipated aircraft transition costs, lower administration and legal costs, improvements in finance income, recognition of gain on an investment in a listed airline". [SP=115.92 Cap=82m]

In line: WEB
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 27-Feb-23
The sin bin for flim flam

Ince (INCE) FY-Mar accounts delayed again as auditor "raised further queries ...in relation to historical accounting treatment". [SP=4.95 Cap=19m]
Deltex Medical (DEMG) repayment date of the £1.1m converts extended from February 2024 to June 2026. [SP=1.02 Cap=8m]
LungLife AI (LLAI) nodule evaluation using LungLB projected to be cost-effective in US healthcare system. [SP=70 Cap=22m]
Forward Partners (FWD) Portfolio Fair Value slightly ahead of expectations at £79m+ at end Dec. That's down 40% exclusive of new and follow-on investments. NAV/sh at least 71p. [SP=38.7 Cap=52m]
Elixirr (ELIX) guides FY-Dec in line with rev up 40% and adj EBITDA c.£20.5m. Thus Q1 Q1 trading ahead of expectations. [SP=420 Cap=194m]
Guild Esports (GILD) launched in January Guild Studios, a new production and creative division "that provides bespoke campaign-led solutions for brands and media owners looking to connect with esports, gaming, Gen-Z and Gen-Alpha [who?] audiences". It has has secured client mandates with brands including Samsung Mobile. Fantastic marketing guff follows. [SP=0.95 Cap=5m]

In line: DCTA, BEG
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

[MrContrarian]

Smallcap Sweep. 28-Feb-23
Movers, groovers and cash hoovers

Nexus Infrastructure (NEXS) to return £63m by tender offer at 163p. [SP=166 Cap=75m]
AO World (AO.) turnround continues as it guides FY-Mar adj EBITDA £37.5m to £45m (from £30m to £40m). Cites "Margin improvement initiatives coupled with a continued resilient underlying customer base". [SP=56.08 Cap=325m]
BrandShield Systems (BRSD) guides FY-Dec rev up 55%. In line? "he current economic climate continues to provide a challenging context for businesses, but our colleagues should be very pleased with these strong results achieved against this backdrop." [SP=5.09 Cap=9m]
ECSC (ECSC) warns FY-Dec small adj EBITDA loss. Rev down 5%. [SP=26.85 Cap=3m]
Safestay (SSTY) guides FY-Dec rev up 196%, ahead of market expectations. Adj EBITDA £5.9m, in line. [SP=21 Cap=14m]
Abingdon Health (ABDX) guides H1-Dec rev £1.1m (£1.7m) but expects FY rev materially up YoY. In line though? Cash in line. [SP=5.2 Cap=6m]
Newmark Security (NWT) AGM stmt - "pleased with the Group's return to profitability in the year to date". But is it in line? [SP=41 Cap=4m]

In line: ESYS, IGE, MCB
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian